Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoadjuvant Therapy × enzalutamide × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 17 Neoplasm Metastasis 3 Neoplasms 2 Metastatic Hormone-sensitive Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer 2 mCRPC 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Lymphoma, Follicular 1 Castration Resistant Metastatic Prostate Cancer 1 Bites and Stings 1 Adenocarcinoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡